Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands
PURPOSE: The fixed-dose dual bronchodilator combination (FDC) of tiotropium and olodaterol showed increased effectiveness regarding lung function and health-related quality of life in patients with chronic obstructive pulmonary disease (COPD) compared with the use of its mono-components. Yet, while effectiveness and safety have been shown, the health economic implication of this treatment is still unknown. The aim of this study was to assess the cost-utility and budget impact of tiotropium-olodaterol FDC in patients with moderate to very severe COPD in the Netherlands. PATIENTS AND METHODS: A... Mehr ...
| Verfasser: |
van Boven, Job Fm
Kocks, Janwillem Wh
Postma, Maarten J |
| Dokumenttyp: |
Artikel |
| Erscheinungsdatum: |
2016 |
| Reihe/Periodikum: |
van Boven , J F , Kocks , J W & Postma , M J 2016 , ' Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands ' , International Journal of Chronic Obstructive Pulmonary Disease , vol. 11 , no. 1 , pp. 2191-2201 . https://doi.org/10.2147/COPD.S114738 |
| Schlagwörter: |
Budget impact
/ COPD
/ Cost-effectiveness
/ Cost–utility
/ Health economics
/ olodaterol plus tiotropium bromide
/ tiotropium bromide
/ age distribution
/ article
/ chronic obstructive lung disease
/ cost effectiveness analysis
/ disease duration
/ disease exacerbation
/ disease severity
/ drug cost
/ forced expiratory volume
/ health care cost
/ human
/ medication compliance
/ Netherlands
/ quality adjusted life year
/ sex difference
/ survival rate
/ treatment duration
/ treatment outcome |
| Sprache: |
Englisch |
| Permalink: |
https://search.fid-benelux.de/Record/base-27601819 |
| Datenquelle: |
BASE;
Originalkatalog |
| Powered By: |
BASE |
| Link(s) :
|
https://hdl.handle.net/11370/b573c5db-77f5-494f-9b40-5f00b0f9f69a |
